Teucrium marum

Other Names

AmberkruidCamedrio maroCat thymeChamaedrys marum (L.) MoenchDərman məryəmnoxuduEixorba-rates blancErba dei gattiGermanderGermandrée des chatsGérmandrée marineGermandrée maritimeGermandrée marumHerb mastichHerba mari verihrdobarka horkákattgamanderKatzen-GamanderKatzenkrautKatžolinis berutisMarum germanderMarum verumMediterranean germandermeriteurikkaožanka koSyrian herb mastichSyrian Mastic ThymeTeucrium marum L.Teucrium marum subsp. drosocalyxTeucrium marum subsp. marumTeucrium marum subsp. occidentale

Synopsis

Teucrium marum (Cat Thyme): A Comprehensive Reference

1. Identity: Botanical Classification, Common Names, and Source

Scientific name: Teucrium marum L. The species name is sometimes rendered in full as Teucrium marum subsp. marum to distinguish it from two closely related subspecies, T. marum subsp. occidentale and T. marum subsp. drosocalyx. In older homeopathic literature it appears as Teucrium marum verum.

Family: Lamiaceae (the mint family).

Common names: The plant is sometimes called the "mint plant" and sometimes also "cat thyme." Additional synonyms include Marum and Amaru; cat thyme is more closely related to the germanders and wood sage (Teucrium sp.) than to any of the thyme herbs. Alternative names for cat thyme include Marum, Amaru, or Mediterranean Germander.

Botanical description: It is a low, multi-branched herb with small, fleshy leaves, and, like most members of its family, is highly aromatic. The Teucrium marum L. complex — comprising subsp. marum, subsp. occidentale, and subsp. drosocalyx — comprises small erect or pulviniform shrubs that grow from sea level up to 2,000 m altitude in the western Mediterranean islands (Corsica, Sardinia, Hyères).

Geographic origin and distribution: The plant is endemic to the western Mediterranean islands, and is a perennial herb native to Southern Europe and the Mediterranean region. The genus Teucrium as a whole comprises over 340 species predominantly found in Mediterranean and temperate regions.

Part used: The aerial parts — leaves, stems, and flowering tops — are the sections of the plant from which essential oils and extracts are typically derived. The extract of Teucrium marum L. (Lamiaceae) is obtained using the aerial parts of the plant, by means of a maceration process.

Common forms and preparations:

Essential oil: Obtained by steam distillation of air-dried aerial parts, typically using a Clevenger apparatus.
Hydroalcoholic extract / maceration: Aqueous or alcoholic macerations of aerial parts, used in both research and traditional herbal contexts.
Infusions and powders: Infusions and powders made from its leaves were used to alleviate coughs, asthma symptoms, and bronchial discomfort.
Homeopathic preparations: The plant is packaged as an unapproved homeopathic OTC drug (e.g., by Boiron). The FDA is not aware of scientific evidence to support homeopathy as effective.
Topical applications: The plant was sometimes applied topically to soothe skin irritations and promote healing.

2. Traditional and Historical Use

Species within the genus Teucrium have been used medicinally for more than two millennia, especially in treating gastrointestinal, inflammatory, and metabolic disorders. Teucrium marum itself has a particularly well-documented ethnobotanical history in the western Mediterranean.

Mediterranean and Sardinian Folk Medicine

In folk medicinal traditions, this plant is used for its antibacterial, anti-inflammatory, and antipyretic activities. In Sardinia, in the Baronia of Siniscola, it has been used in the past to cure malaria.

Historical records suggest that Teucrium marum was employed as a remedy for respiratory ailments, digestive issues, and as a general tonic. In the past, herbalists often recommended it for conditions such as chronic rhinitis and nasal polyps, leveraging its reputed ability to support healthy mucous membranes and clear nasal passages.

Greek, Roman, and Medieval European Use

Teucrium marum verum originates from Mediterranean regions, where it has been used since antiquity. The plant has traditionally been employed for its medicinal properties, especially in treating respiratory and digestive disorders. Historically, it was utilized by Greek and Roman physicians, and its use was preserved in medieval European medicine.

The genus name Teucrium is historically linked to classical antiquity: the botanical name seems likely to have been derived from Teucer, the first King of Troy, who was a pioneer in using this plant for medicinal purposes. The word "amarum" is Latin for "with bitterness" and may have contributed to the species name "marum."

Respiratory and ENT Applications

Herbalists recommended Teucrium marum for conditions such as chronic rhinitis and nasal polyps, leveraging its reputed ability to support healthy mucous membranes and clear nasal passages. Infusions and powders made from its leaves were used to alleviate coughs, asthma symptoms, and bronchial discomfort. A historical record from the 19th century medical literature (Bartlett, 1872, Medical Examiner) specifically documented "beneficial results following, and apparently depending upon, the use of Teucrium Marum in aural polypus."

External Applications

The plant was sometimes applied topically to soothe skin irritations and promote healing. It was also listed in traditional systems for inflammation, pain, scratches, abrasions, external ulcerations, and wounds.

Preparation in Traditional Use

Teucrium marum was rarely used in isolation; it frequently appeared in combination with other botanicals to enhance its benefits. Common traditional preparations included dried herbal infusions (teas), powdered leaf materials blown into nasal passages for polyps, and topical applications of plant material.

3. Key Constituents and Active Compounds

Teucrium marum is phytochemically rich, containing multiple classes of bioactive secondary metabolites, particularly in its essential oil fraction and polar extracts. The chemical composition is notably variable across geographic populations.

Essential Oil Constituents

The essential oil is dominated by sesquiterpenes and iridoid monoterpenes. In a foundational 2005 study by Ricci et al. published in the Journal of Ethnopharmacology, the chemical composition of the essential oil obtained from Teucrium marum subsp. marum (Lamiaceae) was analysed by GC/MS and 30 components were identified. Isocaryophyllene (20.24%), β-bisabolene (14.73%), β-sesquiphellandrene (11.27%), α-santalene (10.97%), dolichodial (9.38%), and α-caryophyllene (7.18%) were the main components.

A 2021 study by Maccioni et al. (Plants, MDPI) analyzing essential oils from Sardinian taxa found somewhat different dominant ratios: the main components detected in the EO obtained from Teucrium marum were β-bisabolene (23.04%), β-sesquiphellandrene (17.78%), 3E-cembrene A (14.01%), and (E)-caryophyllene (9.08%). This illustrates the significant chemotypic variability of the species across collection sites.

Iridoids: Dolichodial and Teucrein

The mint plant, Teucrium marum (family Labiatae), sometimes called cat thyme, contains two methylcyclopentanoid monoterpenes, dolichodial and teucrein. The former compound is potently anti-insectan.

Samples from the Balearic Islands were characterized by a high percentage of dolichodial, an iridoid identified in both the organic solvent extracts and simultaneous distillation–extraction. This compound exerts insecticidal activity and may represent a plant defensive agent.

Teucrein is present at high concentrations in leaf buds, yet dolichodial is present at high levels in mature leaves. Dolichodial has been obtained from teucrein under in vitro conditions, suggesting that teucrein is the precursor of dolichodial.

A 1983 publication by Bellesia et al. (Journal of Chemical Research) identified teucrein as a novel iridolactol from T. marum and described its biosynthetic relationship with dolichodial. The early biosynthetic pathways were further elucidated in subsequent decades.

Polar Extract Constituents: Phenolics and Flavonoids

Verbascoside, caffeic acid derivatives, and flavonols were the main components contained in the polar maceration extract, as detected using high-performance liquid chromatography coupled with a diode array detector (HPLC-DAD). These phenolic constituents are shared across many Teucrium species and are implicated in antioxidant and anti-inflammatory activity.

From a scientific perspective, Teucrium marum contains a variety of bioactive compounds, including flavonoids, diterpenoids, and essential oils, which are believed to contribute to its traditional uses.

Geographic Variability in Phytochemical Composition

Ninety compounds were identified in a 2023 population study: among them, the two compounds that mainly characterised the essential oils of the studied populations — dolichodial and (E)-β-caryophyllene — are of great economic interest. Statistical analyses showed significant differences in phytochemical essential oil composition among and within the studied populations, which clustered following a geographical pattern rather than a simple climatic or edaphic grouping.

4. Mechanisms of Action

Iridoid Biosynthesis and Defensive Chemistry

Cat thyme (Teucrium marum) produces the iridoid dolichodial, which can repel certain insects and attract cats; the compound is also produced by some insect species. A landmark 2024 genomic study (Smit et al., The Plant Journal, 2024) considerably advanced understanding of the biosynthetic basis of these iridoids: the researchers set out to determine the genomic, enzymatic, and evolutionary basis of iridoid biosynthesis in T. marum. They first generated a de novo chromosome-scale genome assembly using Oxford Nanopore Technologies long reads and proximity-by-ligation Hi-C reads. The 610.3 Mb assembly spans 15 pseudomolecules with a 32.9 Mb N50 scaffold size. This allowed for the identification of iridoid-related genes. Researchers discovered that iridoid oxidase (IO) and acetyl transferase (AcT) could work together to produce various iridoids, including dolichodial, thus partially elucidating the dolichodial biosynthetic pathway.

Antioxidant Mechanisms

The antioxidant activity of the essential oil has been evaluated using the DPPH test, 5-lipoxygenase test, and luminol/xanthine/xanthine oxidase chemiluminescence assay. These assays probe different aspects of oxidative radical scavenging and enzyme-mediated oxidation. The phenolic compounds in the plant — particularly verbascoside and caffeic acid derivatives — are well-established antioxidants across the Lamiaceae family.

Antimicrobial Mechanisms

The antimicrobial activity documented for T. marum essential oil is consistent with mechanisms attributed to terpene-rich essential oils in general, including membrane disruption and inhibition of fungal cell wall synthesis. The antimicrobial activity of the essential oil was assayed against four phytopathogenic fungi, and Rhizoctonia solani resulted to be the most sensitive microorganism with a minimum inhibitory concentration (MIC) value of 250 ppm.

Anti-Insectan Defense

Eisner et al. (2000) showed that some methylcyclopentanoid monoterpenes contained in Teucrium marum — dolichodial and teucrein — exert an anti-insectan activity and may represent the plant's chief defensive agent.

5. Scientific Evidence by Area of Use

It is critical to note that rigorous clinical research specifically evaluating the efficacy and safety of Teucrium marum in humans remains limited. Most available data are derived from traditional use and preclinical studies, and well-designed human trials are needed to substantiate its health benefits and establish optimal dosages.

5.1 Antimicrobial Activity

Evidence level: In vitro / preclinical only.

The primary published study on antimicrobial activity is the Ricci et al. 2005 study in the Journal of Ethnopharmacology. The antimicrobial activity of the essential oil was assayed against four phytopathogenic fungi, and Rhizoctonia solani resulted to be the most sensitive microorganism with a MIC value of 250 ppm. The study design involved in vitro assay against plant-pathogenic (not human-pathogenic) fungi, meaning its direct relevance to human infectious disease is indirect at best. No clinical trials in humans for infectious conditions have been identified in the peer-reviewed literature for T. marum specifically.

In folk medicinal traditions, the plant is used for its antibacterial, anti-inflammatory, and antipyretic activities, but these traditional claims have not been evaluated in controlled human studies.

5.2 Antioxidant Activity

Evidence level: In vitro only.

The antioxidant activity of the essential oil was evaluated using the DPPH test, 5-lipoxygenase test, and luminol/xanthine/xanthine oxidase chemiluminescence assay. In a comparison published in subsequent literature, the essential oil of T. marum demonstrated an IC₅₀ value of 13.13 µg/mL in DPPH assays (Ricci et al., 2005, as cited in Bencheikh, 2023). The antioxidant activity is attributed principally to the phenolic content, especially verbascoside and caffeic acid derivatives in the polar extract, and to the sesquiterpene β-caryophyllene in the essential oil. All evidence remains at the in vitro level; no human clinical trials have been conducted.

5.3 Wound Healing and Skin Protection

Evidence level: In vitro / cell-based only.

A 2022 study by Firoznezhad et al., published in Nanomaterials (PubMed PMID: 35407213), tested a T. marum aerial part extract incorporated into novel lipid nanocarriers (hyalurosomes and glycerohyalurosomes) for dermal wound-healing applications. Verbascoside, caffeic acid derivatives, and flavonols were the main components in the extract. The extract was successfully incorporated into hyalurosomes, which were further enriched by adding glycerol (cosolvent) and Tween 80 (surfactant), thus obtaining glycerohyalurosomes. The extract, when loaded in hyalurosomes and glycerohyalurosomes, was able to counteract damages induced in fibroblasts by hydrogen peroxide to a better extent (viability ~110%) than that loaded in other vesicles (viability ~100%), and effectively promoted cell proliferation and migration, ensuring the healing of the wound performed in a cell monolayer (scratch assay) during 48 hours of experiment. Overall, in vitro results confirmed the potential of glycerohyalurosomes as delivery systems for T. marum extract for the treatment of skin lesions connected with oxidative stress. This study is in vitro only; no animal or human data are available for this specific application.

5.4 Respiratory and Nasal Conditions (Nasal Polyps, Catarrh)

Evidence level: Traditional / historical use only; no controlled clinical evidence.

Herbalists historically recommended Teucrium marum for conditions such as chronic rhinitis and nasal polyps, leveraging its reputed ability to support healthy mucous membranes and clear nasal passages. This indication has been codified in 19th-century homeopathic literature (e.g., Bartlett, 1872, on its use in aural polypus) and persists in contemporary homeopathic prescribing. No peer-reviewed controlled human trials assessing T. marum for nasal polyps, rhinitis, or related respiratory conditions have been identified. The homeopathic preparations sold under this indication are classified by the FDA as unapproved, and the FDA is not aware of scientific evidence to support homeopathy as effective.

5.5 Anti-Inflammatory Activity

Evidence level: Traditional use; no direct human clinical evidence for T. marum specifically.

In folk medicinal traditions, this plant is used for its anti-inflammatory activities. Broader genus-level research across the Lamiaceae family has documented anti-inflammatory mechanisms (e.g., inhibition of COX enzymes, modulation of cytokine production) for various Teucrium species, and the sesquiterpene β-caryophyllene — a major constituent of T. marum essential oil — is a documented CB2 receptor agonist with anti-inflammatory properties. However, no published human clinical trial has specifically evaluated T. marum extract for anti-inflammatory endpoints.

5.6 Antiparasitic / Anthelmintic Indications

Evidence level: Traditional use; no clinical evidence.

In traditional medicine, many pharmacological activities have been ascribed to the genus Teucrium, including antirheumatic, antispasmodic, anthelmintic, diuretic, antidiabetic, and anticancer effects. The homeopathic literature specifically references the species for pinworm infestation. No scientific clinical evidence substantiates this use for T. marum specifically.

5.7 Iridoid Biosynthesis Research (Mechanistic/Genomic Science)

Evidence level: Peer-reviewed basic science (genomics); not a clinical health application.

The most rigorous recent research on T. marum has focused on elucidating the plant's unique biosynthetic machinery. The iridoid dolichodial, produced by Teucrium marum and multiple insect species, has highly similar properties to nepetalactone, but its biosynthetic origin was previously unknown. Researchers set out to determine the genomic, enzymatic, and evolutionary basis of iridoid biosynthesis. A de novo chromosome-scale genome assembly was generated using Oxford Nanopore Technologies long reads and Hi-C reads. The 610.3 Mb assembly spans 15 pseudomolecules with a 32.9 Mb N50 scaffold size. This enabled identification of iridoid biosynthetic genes, whose roles were verified via activity assays. This genomic work (Smit et al., The Plant Journal, 2024) does not directly inform clinical use but provides a scientific foundation for understanding the plant's bioactive compound production.

6. Body Systems and Health Areas of Association

Based on the combined traditional use record and available preclinical scientific data, Teucrium marum has been associated with the following body systems and health areas:

Respiratory system: Historical use for respiratory ailments including coughs, asthma, bronchial discomfort, rhinitis, and nasal polyps.
Digestive system: The plant has traditionally been employed for treating digestive disorders.
Integumentary (skin) system: In vitro results have confirmed potential for T. marum extract as a delivery agent for skin lesions connected with oxidative stress.
Immune and anti-infective functions: Traditional use for antipyretic and antibacterial purposes; in vitro antifungal activity documented against phytopathogenic fungi.
Musculoskeletal / pain: Listed in traditional records for inflammation, pain, and arthritis-type conditions.
Parasitic infections: Traditional and homeopathic use for pinworm and related conditions (no clinical evidence).

7. Dosage Forms and Reported Dosages

No established clinical human dosages for Teucrium marum have been validated in controlled trials. The following are reported only as they appear in the identified sources:

Homeopathic preparations: A commercial homeopathic product (Boiron) contains Teucrium marum 30C, at 0.443 mg of the active ingredient per pellet. This ultra-dilute preparation contains no detectable amount of the crude plant material.
Traditional powdered leaf: For nasal polyps, a dry powder has historically been used for local application. No validated dose is specified in peer-reviewed sources.
Essential oil (research use): In the 2005 Ricci et al. study, the essential oil was used in in vitro antimicrobial assays; the most sensitive organism tested showed activity at an MIC of 250 ppm. These are laboratory concentrations, not doses for human use.
Extract (research use): In the 2022 Firoznezhad et al. Nanomaterials study, the plant extract was incorporated into nanocarrier formulations for in vitro testing. No human dose was established.

No regulatory body (EMA, ESCOP, WHO, or Commission E) has issued a formal monograph or approved posological guidance for Teucrium marum specifically.

8. Safety Considerations

Genus-Level Hepatotoxicity Concern

The most significant and evidence-supported safety concern relating to Teucrium marum is its membership in a genus with established hepatotoxic species. Despite their long history of medicinal use, Teucrium species are associated with significant hepatotoxicity, which has raised safety concerns regarding their use.

The genus Teucrium L. has a long-term use in folk medicine; however, there are implications for human health related to the consumption of germander-containing products. Numerous cases of hepatotoxicity have been reported, mostly in Europe, where the plants were used as herbal products for weight loss and still are used in folklore medicine to treat hypercholesterolemia and diabetes. During the last decades, several cases of germander toxicity including chronic hepatitis as well as acute cytolytic hepatitis and a case of death have been reported.

The most well-known toxic Teucrium species are Teucrium chamaedrys, T. polium, and T. capitatum. The neo-clerodane diterpenoids occurring in Teucrium species have been the subject of intensive studies, since they have been correlated to the toxic effects of the genus.

Mechanism of Hepatotoxicity (Established for Related Species)

The hepatotoxic mechanism has been rigorously studied for T. chamaedrys (germander), the species most implicated in liver injury reports. The hepatotoxicity of the herbal plant germander and that of one of its major furanoneoclerodane diterpenes, teucrin A, were investigated in mice. Teucrin A was found to cause the same midzonal hepatic necrosis as observed with extracts of the powdered plant material. Evidence that bioactivation of teucrin A by cytochromes P450 to a reactive metabolite(s) is required for initiation of the hepatocellular damage was provided by experiments on induction and inhibition of P450 and studies on the effects of glutathione depletion.

Pretreatment of mice with the P450 inducer phenobarbital enhanced the hepatotoxic response, as indicated by an increase in plasma ALT levels and hepatic necrosis, while pretreatment with the P450 inhibitor piperonyl butoxide markedly attenuated the toxic response. Hepatotoxicity of teucrin A was also increased following pretreatment with the inhibitor of glutathione synthesis buthionine sulfoximine. The tetrahydrofuran analog of teucrin A, obtained by selective chemical reduction of the furan ring, was not hepatotoxic, providing strong evidence that oxidation of the furan ring moiety of the neoclerodane diterpenes is involved in the initiation of hepatocellular injury.

Neoclerodane diterpenoids are metabolized by CYP3A to form a reactive enedial involved in the mechanism of toxicity. The toxicity of teucrin A has been attributed to the metabolic activation of the 3-substituted furan ring to an electrophilic metabolite. Oral administration of germander extracts or teucrin A results in depletion of cellular GSH and damage to protein thiols, which results in elevated ALT activity and significant centrilobular necrosis in mice.

Relevance to T. marum Specifically

Some Teucrium species are toxic to the liver. The phytochemical literature on T. marum has not to date identified furano-neoclerodane diterpenoids (the specific class linked to hepatotoxicity in T. chamaedrys) as major constituents; the dominant constituents are sesquiterpenes and cyclopentanoid iridoids. Nevertheless, the structural diversity within the genus and the documented variability in T. marum's chemical profile across populations mean that the genus-level hepatotoxicity concern remains relevant as a precautionary matter until species-specific human safety data are available.

CYP3A4 Interaction Potential

Because the hepatotoxic mechanism in related Teucrium species involves CYP3A4-mediated bioactivation of furan-containing constituents, the use of Teucrium preparations alongside CYP3A4-inducing or -inhibiting drugs is a recognized pharmacokinetic interaction concern for the genus. No specific interaction studies have been published for T. marum in humans.

Lack of Clinical Safety Data

Rigorous clinical research specifically evaluating the efficacy and safety of Teucrium marum in humans remains limited. Most available data are derived from traditional use and preclinical studies, and well-designed human trials are needed to substantiate its health benefits and establish optimal dosages.

9. Summary of Evidence Strength

Phytochemical composition (essential oil): Well-characterized by multiple peer-reviewed GC/MS analyses; chemotypic variability across populations documented in multiple studies.
Genomic and biosynthetic basis of iridoids: Established by rigorous 2024 chromosome-scale genomic study (The Plant Journal).
In vitro antifungal activity: One primary peer-reviewed study; limited to phytopathogenic organisms; no human relevance established.
In vitro antioxidant activity: Demonstrated in one primary peer-reviewed study using established assays; no human trials.
In vitro wound-healing potential: Demonstrated in one cell-based study with nanocarrier formulation; no animal or human data.
Traditional respiratory / nasal polyp use: Historical use record only; no clinical evidence.
Homeopathic use: No scientific clinical evidence; FDA classification as unapproved with no evidentiary support.
Safety (hepatotoxicity): Genus-level concern well-established by human case reports and mechanistic animal studies for related species; species-specific toxicology data for T. marum are absent from the peer-reviewed literature.

References

Health Conditions

Health conditions that Teucrium marum may help support.

No conditions available.

Body Systems

Body systems that Teucrium marum may help support.

No body systems available.